Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 2,562.20
-73.60 (-2.79%)
Aug 6, 2025, 11:30 AM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 329.18 billion as of August 5, 2025. Its market cap has increased by 15.22% in one year.
Market Cap
329.18B
Enterprise Value
323.55B
Revenue
48.06B
Ranking
n/a
PE Ratio
35.42
Stock Price
2,562.20
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 329.18B, an increase of 58,079.87%. That is a compound annual growth rate of 31.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 329.18B | -10.11% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | 141.32B | 66.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,915.95B |
| Divi's Laboratories | 1,701.39B |
| Cipla | 1,211.47B |
| Mankind Pharma | 1,080.90B |
| Apollo Hospitals Enterprise | 1,045.89B |
| Zydus Lifesciences | 966.24B |
| Fortis Healthcare | 655.23B |
| Aurobindo Pharma | 626.86B |